InvestorsHub Logo
Followers 0
Posts 75
Boards Moderated 0
Alias Born 03/21/2024

Re: None

Monday, 03/25/2024 3:53:02 PM

Monday, March 25, 2024 3:53:02 PM

Post# of 43057
Taran paid only paid net $1,265,831 for all the assets cash, liquid receivables with it's $2 million dollar bid as the assets had a asset value of 736,470. HGEN reported the sale as 'revenue' when it is not really revenue. but capital loss. it's asset were sold like 99% loss. HGEN can claim 100 million in capital loss . Investors valued the assets at over 100 million when ipo so technically a loss if FDA didn't approve their patent. But for some reason the CFO won't report the over 100 million as capital loss. As shell company with over 100 million capital loss it can be sold just tax purpose but management seems to have another agenda. The assets of hgen was valued at over 100 million when it ipo in nasdaq. now the assets are worth 0 that is capital loss of 100 million.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.